{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:19:56Z","timestamp":1792261196887,"version":"4.4.0"},"reference-count":92,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP200081"],"award-info":[{"award-number":["RP200081"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP200509"],"award-info":[{"award-number":["RP200509"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the sixth most common cancer and fourth leading cause of cancer-related death worldwide. The number of HCC cases continues to rise despite advances in screening and therapeutic inventions. More importantly, HCC poses two major health disparity issues. First, HCC occurs more commonly in men than women. Second, with the global increase in non-alcoholic fatty liver diseases (NAFLD), it has also become evident that HCC is more prevalent in some races and\/or ethnic groups compared to others, depending on its predisposing etiology. Most studies on HCC in the past have been focused on genetic factors as the driving force for HCC development, and the results revealed that genetic mutations associated with HCC are often heterogeneous and involve multiple pathogenic pathways. An emerging new research field is epigenetics, in which gene expression is modified without altering DNA sequences. In this article, we focus on reviewing current knowledge on HCC-related DNA methylation changes that show disparities among different sexes or different racial\/ethnic groups, in an effort to establish a point of departure for resolving the broader issue of health disparities in gastrointestinal malignancies using cutting-edge epigenetic approaches.<\/jats:p>","DOI":"10.3390\/ijms22083820","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T11:31:59Z","timestamp":1617795119000},"page":"3820","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Sex and Race-Related DNA Methylation Changes in Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"22","author":[{"given":"Wenrui","family":"Ye","sequence":"first","affiliation":[{"name":"Institute of Biosciences and Technology, Texas A&amp;M Health Science Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Siwko","sequence":"additional","affiliation":[{"name":"Institute of Biosciences and Technology, Texas A&amp;M Health Science Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-0812","authenticated-orcid":false,"given":"Robert Y. L.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Institute of Biosciences and Technology, Texas A&amp;M Health Science Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"53","article-title":"Colorectal cancer incidence and screening-United States, 2008 and 2010","volume":"62","author":"Steele","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: Consider the population","volume":"47","author":"Mittal","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.30161","article-title":"Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Altekruse","year":"2016","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2016.08.013","article-title":"Time trends of chronic HBV infection over prior decades\u2014A global analysis","volume":"66","author":"Ott","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3322\/caac.21402","article-title":"Disparities in liver cancer occurrence in the United States by race\/ethnicity and state","volume":"67","author":"Islami","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1073\/pnas.94.6.2103","article-title":"Altered DNA methylation and genome instability: A new pathway to cancer?","volume":"94","author":"Jones","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/sj.onc.1204438","article-title":"Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer","volume":"20","author":"Umbricht","year":"2001","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg.2017.33","article-title":"TET-mediated active DNA demethylation: Mechanism, function and beyond","volume":"18","author":"Wu","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1093\/nar\/gks845","article-title":"Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: Its structural basis and implications for active DNA demethylation","volume":"40","author":"Hashimoto","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cell.2011.06.020","article-title":"Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair","volume":"146","author":"Cortellino","year":"2011","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bronner, C., Alhosin, M., Hamiche, A., and Mousli, M. (2019). Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns. Genes, 10.","DOI":"10.3390\/genes10010065"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gujar, H., Weisenberger, D.J., and Liang, G. (2019). The roles of human DNA methyltransferases and their isoforms in shaping the epigenome. Genes, 10.","DOI":"10.3390\/genes10020172"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/CIRCRESAHA.116.303630","article-title":"Readers, writers, and erasers: Chromatin as the whiteboard of heart disease","volume":"116","author":"Gillette","year":"2015","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/emm.2017.11","article-title":"Writing, erasing and reading histone lysine methylations","volume":"49","author":"Hyun","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0959-437X(99)80026-4","article-title":"Histone acetylation and cancer","volume":"9","author":"Archer","year":"1999","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12640-014-9508-6","article-title":"A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs","volume":"27","author":"Filip","year":"2015","journal-title":"Neurotox. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1073\/pnas.90.24.11995","article-title":"Number of CpG islands and genes in human and mouse","volume":"90","author":"Antequera","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000484104","article-title":"Long interspersed Element-1 methylation level as a prognostic biomarker in gastrointestinal cancers","volume":"97","author":"Baba","year":"2018","journal-title":"Digestion"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ebiom.2015.03.015","article-title":"P16 Methylation as an early predictor for cancer development from oral epithelial dysplasia: A double-blind multicentre prospective study","volume":"2","author":"Liu","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3748\/wjg.v7.i5.722","article-title":"P16 gene methylation in colorectal cancers associated with Duke\u2019s staging","volume":"7","author":"Yi","year":"2001","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ye, X., Mo, M., Xu, S., Yang, Q., Wu, M., Zhang, J., Chen, B., Li, J., Zhong, Y., and Huang, Q. (2018). The hypermethylation of p16 gene exon 1 and exon 2: Potential biomarkers for colorectal cancer and are associated with cancer pathological staging. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4921-5"},{"key":"ref_28","first-page":"2229","article-title":"Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors","volume":"57","author":"Stirzaker","year":"1997","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","article-title":"Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma","volume":"91","author":"Herman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/jmv.25221","article-title":"Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population","volume":"90","author":"Maryam","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/1940-6207.CAPR-15-0349","article-title":"DNA hypomethylation contributes to genomic instability and intestinal cancer initiation","volume":"9","author":"Sheaffer","year":"2016","journal-title":"Cancer Prev. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0888-7543(89)90137-7","article-title":"CpG dinucleotides are mutation hot spots in phenylketonuria","volume":"5","author":"Abadie","year":"1989","journal-title":"Genomics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.1697983","article-title":"5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes","volume":"249","author":"Rideout","year":"1990","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/513898","article-title":"Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1)","volume":"61","author":"Mancini","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1098-2280(1998)32:2<188::AID-EM16>3.0.CO;2-Y","article-title":"Transition mutations at CpG dinucleotides are the most frequent in vivo spontaneous single-based substitution mutation in the human HPRT gene","volume":"32","author":"Finette","year":"1998","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/humu.20132","article-title":"Mutation rates in the dystrophin gene: A hotspot of mutation at a CpG dinucleotide","volume":"25","author":"Buzin","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1073\/pnas.94.8.3893","article-title":"Cytosine methylation determines hot spots of DNA damage in the human P53 gene","volume":"94","author":"Denissenko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ijc.23979","article-title":"Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility","volume":"124","author":"Liao","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.meegid.2009.05.012","article-title":"Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population","volume":"9","author":"Ezzikouri","year":"2009","journal-title":"Infect. Genet. Evol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, H.F., Mai, J.R., Wan, J.X., Gao, Y.F., Lin, L.N., Wang, S.Z., Chen, Y.X., Zhang, C.Z., Zhang, Y.J., and Xia, B. (2013). Role of a novel functional variant in the PPP2R1A promoter on the regulation of PP2A-Aalpha and the risk of hepatocellular carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059574"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/labinvest.2011.169","article-title":"A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype","volume":"92","author":"Banelli","year":"2012","journal-title":"Lab. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/epi.23062","article-title":"Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips","volume":"8","author":"Shen","year":"2013","journal-title":"Epigenetics"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Varghese, R.S., Zhou, Y., Chen, Y., Barefoot, M.E., Tadesse, M., and Ressom, H.W. (2020, January 20\u201324). Epigenetic changes associated with mechanisms of disparities in hepatocellular carcinoma. Proceedings of the 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), Montreal, QC, Canada.","DOI":"10.1109\/EMBC44109.2020.9176036"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2217\/epi.11.105","article-title":"Evaluation of the infinium methylation 450K technology","volume":"3","author":"Dedeurwaerder","year":"2011","journal-title":"Epigenomics"},{"key":"ref_45","first-page":"3516","article-title":"Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients","volume":"6","author":"Wong","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cca.2010.01.004","article-title":"Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma","volume":"411","author":"Tsutsui","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/138920211795564359","article-title":"Genetic and epigenetic signatures in human hepatocellular carcinoma: A systematic review","volume":"12","author":"Nishida","year":"2011","journal-title":"Curr. Genom."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3748\/wjg.v17.i25.3043","article-title":"P16 gene hypermethylation and hepatocellular carcinoma: A systematic review and meta-analysis","volume":"17","author":"Zang","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1158\/1078-0432.CCR-04-1715","article-title":"p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma","volume":"10","author":"Li","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1478-3231.2011.02696.x","article-title":"Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma","volume":"32","author":"Wang","year":"2012","journal-title":"Liver Int."},{"key":"ref_51","first-page":"501","article-title":"Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer","volume":"8","author":"Wiencke","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Li, P., Zhang, X., Gu, L., Zhou, J., and Deng, D. (2019). P16 methylation increases the sensitivity of cancer cells to the CDK4\/6 inhibitor palbociclib. PLoS ONE, 14.","DOI":"10.1101\/771337"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2018.10.009","article-title":"Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma","volume":"683","author":"Zhou","year":"2019","journal-title":"Gene"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"152920","DOI":"10.1016\/j.prp.2020.152920","article-title":"Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma","volume":"216","author":"Yi","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mrrev.2018.09.003","article-title":"Line-1: Implications in the etiology of cancer, clinical applications, and pharmacologic targets","volume":"778","author":"Khalid","year":"2018","journal-title":"Mutat. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/toxsci\/kfg138","article-title":"The long (LINEs) and the short (SINEs) of it: Altered methylation as a precursor to toxicity","volume":"75","author":"Carnell","year":"2003","journal-title":"Toxicol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S729","DOI":"10.1245\/s10434-014-3874-4","article-title":"Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/1078-0432.CCR-08-0266","article-title":"Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma","volume":"15","author":"Lee","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_59","first-page":"849","article-title":"Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene","volume":"9","author":"Stern","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7754\/Clin.Lab.2019.190906","article-title":"LINE-1 methylation in chronic HBV infected patients: Association with HCC, gender and MTHFR C677T polymorphism","volume":"66","author":"Qiao","year":"2020","journal-title":"Clin. Lab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.3748\/wjg.v17.i42.4718","article-title":"CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis","volume":"17","author":"Liu","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fgene.2019.01299","article-title":"Association of TNFRSF12A methylation with prognosis in hepatocellular carcinoma with history of alcohol consumption","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20031675","article-title":"SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis","volume":"199","author":"Yoshida","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jvh.12137","article-title":"An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma","volume":"21","author":"Zhang","year":"2014","journal-title":"J. Viral. Hepat."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhang, X., Liu, Y., Lu, F., and Chen, X. (2016). Decreased expression of BNC1 and BNC2 is associated with genetic or epigenetic regulation in hepatocellular carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020153"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmv.20771","article-title":"Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program","volume":"79","author":"Su","year":"2007","journal-title":"J. Med. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8219536","DOI":"10.1155\/2020\/8219536","article-title":"Prevalence of hepatitis C virus infection in a surgical population of Southeast China: A large-scale multicenter study","volume":"2020","author":"Chen","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2174\/13816128113199990533","article-title":"Epigenetic mechanism involved in the HBV\/HCV-related hepatocellular carcinoma tumorigenesis","volume":"20","author":"Rongrui","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12250-015-3582-7","article-title":"Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma","volume":"30","author":"Tian","year":"2015","journal-title":"Virol. Sin."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjc.6604422","article-title":"Common dysregulation of Wnt\/Frizzled receptor elements in human hepatocellular carcinoma","volume":"99","author":"Bengochea","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/JHC.S156701","article-title":"Role of Wnt\/beta-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance","volume":"5","author":"Khalaf","year":"2018","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<644::AID-IJC3>3.0.CO;2-V","article-title":"Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma","volume":"70","author":"Hiltunen","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0002-9440(10)65496-X","article-title":"Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection","volume":"155","author":"Huang","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/CEJ.0000000000000121","article-title":"Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: A meta-analysis","volume":"24","author":"Liu","year":"2015","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chen, J., Zhao, J., Ma, R., Lin, H., Liang, X., and Cai, X. (2014). Prognostic significance of E-cadherin expression in hepatocellular carcinoma: A meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103952"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1440-1746.2004.03361.x","article-title":"Cadherin\/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa","volume":"19","author":"Herath","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/ijo_00000423","article-title":"Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas","volume":"35","author":"Herath","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.7314\/APJCP.2014.15.16.6591","article-title":"Role of P14 and MGMT gene methylation in hepatocellular carcinomas: A meta-analysis","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chiam, K., Centenera, M.M., Butler, L.M., Tilley, W.D., and Bianco-Miotto, T. (2011). GSTP1 DNA methylation and expression status is indicative of 5-aza-2\u2019-deoxycytidine efficacy in human prostate cancer cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025634"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1600-0676.2003.00834.x","article-title":"No association between GSTP1 gene aberrant promoter methylation and prognosis in surgically resected hepatocellular carcinoma patients from the Basque Country (Northern Spain)","volume":"23","author":"Anzola","year":"2003","journal-title":"Liver Int."},{"key":"ref_82","first-page":"663","article-title":"GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas","volume":"16","author":"Tchou","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.21735","article-title":"Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma","volume":"46","author":"Yuan","year":"2007","journal-title":"Hepatology"},{"key":"ref_84","first-page":"4992","article-title":"A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer","volume":"62","author":"Shen","year":"2002","journal-title":"Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.3748\/wjg.v13.45.6082","article-title":"DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: A case-control study","volume":"13","author":"Wu","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/hep.22975","article-title":"Epidemiology of hepatitis B in the United States","volume":"49","author":"Kim","year":"2009","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"McCormick, H., Young, P.E., Hur, S.S.J., Booher, K., Chung, H., Cropley, J.E., Giannoulatou, E., and Suter, C.M. (2017). Isogenic mice exhibit sexually-dimorphic DNA methylation patterns across multiple tissues. BMC Genom., 18.","DOI":"10.1186\/s12864-017-4350-x"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat. Mater."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/carcin\/bgx078","article-title":"Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population","volume":"38","author":"Wu","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1515\/cclm-2017-0703","article-title":"GSTP1 methylation in cancer: A liquid biopsy biomarker?","volume":"56","author":"Gurioli","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ebiom.2018.03.029","article-title":"Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based epigenetic biomarker to diagnose hepatocellular carcinoma","volume":"30","author":"Oussalah","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09674845.2019.1694123","article-title":"Methylation of tumour suppressor genes RUNX3, RASSF1A and E-Cadherin in HCV-related liver cirrhosis and hepatocellular carcinoma","volume":"77","author":"Nour","year":"2020","journal-title":"Br. J. Biomed. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/8\/3820\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:34:14Z","timestamp":1760362454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/8\/3820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":92,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22083820"],"URL":"https:\/\/doi.org\/10.3390\/ijms22083820","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]}}}